F. Scheiflinger

752 total citations
25 papers, 594 citations indexed

About

F. Scheiflinger is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, F. Scheiflinger has authored 25 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 13 papers in Immunology and 10 papers in Genetics. Recurrent topics in F. Scheiflinger's work include Hemophilia Treatment and Research (12 papers), Platelet Disorders and Treatments (11 papers) and Complement system in diseases (11 papers). F. Scheiflinger is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Platelet Disorders and Treatments (11 papers) and Complement system in diseases (11 papers). F. Scheiflinger collaborates with scholars based in Austria, Netherlands and United States. F. Scheiflinger's co-authors include Michael Dockal, Rudolf Hartmann, Hanspeter Rottensteiner, Peter L. Turecek, Leonard A. Valentino, Jan Rosing, Albert Hofman, Marileen L.P. Portegies, Michelle Sonneveld and Frank W.G. Leebeek and has published in prestigious journals such as Blood, European Journal of Cancer and Critical Care.

In The Last Decade

F. Scheiflinger

25 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Scheiflinger Austria 14 405 224 180 67 63 25 594
Nele Vandeputte Belgium 15 427 1.1× 445 2.0× 193 1.1× 74 1.1× 136 2.2× 23 710
Masami Niiya Japan 10 148 0.4× 191 0.9× 72 0.4× 94 1.4× 56 0.9× 20 377
Veysel Sabri Hançer Türkiye 11 125 0.3× 121 0.5× 52 0.3× 66 1.0× 81 1.3× 47 378
K Horie Japan 8 370 0.9× 117 0.5× 82 0.5× 64 1.0× 15 0.2× 8 509
Cécile Contin France 4 151 0.4× 140 0.6× 37 0.2× 48 0.7× 21 0.3× 6 371
Fanli Hua China 13 256 0.6× 138 0.6× 56 0.3× 116 1.7× 30 0.5× 31 476
SA Burstein United States 11 398 1.0× 97 0.4× 103 0.6× 125 1.9× 21 0.3× 20 575
Ria C. Boertjes Netherlands 6 246 0.6× 72 0.3× 74 0.4× 35 0.5× 13 0.2× 6 355
Nikolett Wohner Hungary 12 287 0.7× 101 0.5× 54 0.3× 48 0.7× 17 0.3× 16 474
Abdullah Hacıhanefioğlu Türkiye 11 222 0.5× 52 0.2× 55 0.3× 124 1.9× 36 0.6× 30 424

Countries citing papers authored by F. Scheiflinger

Since Specialization
Citations

This map shows the geographic impact of F. Scheiflinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Scheiflinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Scheiflinger more than expected).

Fields of papers citing papers by F. Scheiflinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Scheiflinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Scheiflinger. The network helps show where F. Scheiflinger may publish in the future.

Co-authorship network of co-authors of F. Scheiflinger

This figure shows the co-authorship network connecting the top 25 collaborators of F. Scheiflinger. A scholar is included among the top collaborators of F. Scheiflinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Scheiflinger. F. Scheiflinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartmann, Rudolf, et al.. (2018). In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents. Journal of Thrombosis and Haemostasis. 16(8). 1580–1591. 71 indexed citations
2.
Piskernik, Christina, Barbara Plaimauer, Frank Horling, et al.. (2016). Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 14(7). 1410–1419. 21 indexed citations
3.
Sonneveld, Michelle, Moniek P.M. de Maat, Marileen L.P. Portegies, et al.. (2015). Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood. 126(25). 2739–2746. 122 indexed citations
4.
Tersteeg, Claudia, Alexandra Schiviz, Barbara Plaimauer, et al.. (2015). Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats. Journal of Thrombosis and Haemostasis. 13. 152–152. 1 indexed citations
5.
6.
Thomassen, Stella, Alexandra C.A. Heinzmann, Jan Rosing, et al.. (2014). Inhibition of tissue factor:factor VIIa–catalyzed factor IX and factor X activation by TFPI and TFPI constructs. Journal of Thrombosis and Haemostasis. 12(11). 1826–1837. 23 indexed citations
7.
Skalicky, Susanna, Paul Knöbl, Barbara Plaimauer, et al.. (2014). A novel flow‐based assay reveals discrepancies in ADAMTS‐13 inhibitor assessment as compared with a conventional clinical static assay. Journal of Thrombosis and Haemostasis. 12(9). 1523–1532. 3 indexed citations
8.
Thomassen, Stella, Alexandra C.A. Heinzmann, Rudolf Hartmann, et al.. (2014). Tissue factor‐independent inhibition of thrombin generation by tissue factor pathway inhibitor‐α. Journal of Thrombosis and Haemostasis. 13(1). 92–100. 16 indexed citations
9.
Knappe, Sabine, Bernd Jilma, Ulla Derhaschnig, et al.. (2013). Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood. Thrombosis and Haemostasis. 109(3). 450–457. 19 indexed citations
10.
Thomassen, Stella, Alexandra C.A. Heinzmann, Jan Rosing, et al.. (2013). Direct inhibition of factor VIIa by TFPI and TFPI constructs. Journal of Thrombosis and Haemostasis. 11(4). 704–714. 21 indexed citations
11.
Waters, Emily K., Ryan M. Genga, Heather A. Thomson, et al.. (2013). Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein. Journal of Thrombosis and Haemostasis. 11(6). 1137–1145. 37 indexed citations
12.
Zhou, Z. Hong, W. Stratford May, Chunlei Wang, et al.. (2010). Disulfide bond reduction of von Willebrand factor by ADAMTS‐13. Journal of Thrombosis and Haemostasis. 8(12). 2778–2788. 40 indexed citations
13.
Váradi, Katalin, Hanspeter Rottensteiner, Susanne Vejda, et al.. (2009). Species‐dependent variability of ADAMTS13‐mediated proteolysis of human recombinant von Willebrand factor. Journal of Thrombosis and Haemostasis. 7(7). 1134–1142. 16 indexed citations
14.
Hartmann, Rudolf, Michael Dockal, Gerry A. F. Nicolaes, et al.. (2009). Factor IX mutants with enhanced catalytic activity. Journal of Thrombosis and Haemostasis. 7(10). 1656–1662. 12 indexed citations
15.
Scheiflinger, F., Michael Dockal, Jan Rosing, & Randolf J. Kerschbaumer. (2008). Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies. Journal of Thrombosis and Haemostasis. 6(2). 315–322. 6 indexed citations
16.
Pos, Wouter, Brenda M. Luken, Johanna A. Kremer Hovinga, et al.. (2008). VH1‐69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 7(3). 421–428. 45 indexed citations
17.
Scheiflinger, F., Michael Dockal, Jan Rosing, & Randolf J. Kerschbaumer. (2008). Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies. Journal of Thrombosis and Haemostasis. 6(2). 315–322. 6 indexed citations
18.
Niiya, Masami, Masayuki Uemura, Xiangjian Zheng, et al.. (2006). Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. Journal of Thrombosis and Haemostasis. 4(5). 1063–1070. 47 indexed citations
19.
Völkel, Dirk, Barbara Plaimauer, G. Antoine, et al.. (2005). Cloning, expression and functional characterization of the full‐length murine ADAMTS13. Journal of Thrombosis and Haemostasis. 3(5). 1064–1073. 9 indexed citations
20.
Váradi, Katalin, Barbara Plaimauer, Manfred Rieger, et al.. (2003). ADAMTS13 autoantibody detection by quantitative immunoblotting. Blood. 102(5). 1932–1933. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nele Vandeputte Breakdown of academic impact, for papers by Masami Niiya Breakdown of academic impact, for papers by Veysel Sabri Hançer Breakdown of academic impact, for papers by K Horie Breakdown of academic impact, for papers by Cécile Contin Breakdown of academic impact, for papers by Fanli Hua Breakdown of academic impact, for papers by SA Burstein Breakdown of academic impact, for papers by Ria C. Boertjes Breakdown of academic impact, for papers by Nikolett Wohner Breakdown of academic impact, for papers by Abdullah Hacıhanefioğlu
Rankless by CCL
2026